National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021
Identifying and definitional attributes
|Metadata item type:||Indicator|
|Indicator type:||Progress measure|
|Short name:||PI 02–Incidence of selected cancers, 2021|
|Registration status:||Health, Standard 16/09/2020|
Incidence of selected cancers of public health importance.
|Indicator set:||National Healthcare Agreement (2021) Health, Standard 19/11/2020|
|Outcome area:||Prevention Health, Standard 07/07/2010|
Collection and usage attributes
Rates directly age-standardised to the 2001 Australian Standard Population.
Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) are based on the Statistical Area Level 2 (SA2) of the person at the time of their diagnosis.
Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published.
100,000 × (Numerator ÷ Denominator)
Calculated separately for each type of cancer.
For melanoma, bowel and lung cancer: Number of new cases in the reported year.
For cervical and breast cancer in females: Number of new cases in females in the reported year.
|Numerator data elements:|
For melanoma, bowel and lung cancer: Total population.
For cervical and breast cancer in females: Total female population.
|Denominator data elements:|
2016, 2017, 2018 — State and territory, by:
2016, 2017, 2018 — Nationally, by:
Cancer types in these disaggregations comprise: bowel cancer (ICD-10 2016 version codes C18–C20), lung cancer (C33–C34), melanoma of the skin (C43), female breast cancer (C50) and cervical cancer (C53).
The 2018 tables only include data from Victoria.
Some disaggregation may result in numbers too small for publication.
|Disaggregation data elements:|
Most recent data available for 2021 National Healthcare Agreement performance reporting: 2018 for Victoria; 2017 for New South Wales, Queensland, Western Australia, South Australia, Tasmania and the Australian Capital Territory; 2016 for the Northern Territory.
|Unit of measure:||Episode|
Indicator conceptual framework
|Framework and dimensions:||Health conditions|
Data source attributes
National Healthcare Agreement
|Organisation responsible for providing data:|
Australian Institute of Health and Welfare
|Further data development / collection required:|
Specification: Final, the measure meets the intention of the indicator.
|Related metadata references:|
See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2019 Health, Standard 09/04/2020
See also Australian Health Performance Framework: PI 3.1.2–Incidence of selected cancers, 2019 Health, Standard 09/04/2020
Supersedes National Healthcare Agreement: PI 02–Incidence of selected cancers, 2020 Health, Standard 13/03/2020
Has been superseded by National Healthcare Agreement: PI 02–Incidence of selected cancers, 2022 Health, Standardisation pending 20/07/2021
See also National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2021 Health, Standard 16/09/2020